View - ResearchGate
View - ResearchGate View - ResearchGate
18 Plasmid DNA Purification Via the Use of a Dual Affinity Protein Gareth M. Forde Summary Methods are presented for the production, affinity purification and analysis of plasmid DNA (pDNA). Batch fermentation is used for the production of the pDNA, and expanded bed chromatography, via the use of a dual affinity glutathione S-transferase (GST) fusion protein, is used for the capture and purification of the pDNA. The protein is composed of GST, which displays affinity for glutathione immobilized to a solid-phase adsorbent, fused to a zinc finger transcription factor, which displays affinity for a target 9-base pair sequence contained within the target pDNA. A Picogreen fluorescence assay and/or an ethidium bromide agarose gel electrophoresis assay can be used to analyze the eluted pDNA. Key Words: Plasmid DNA; affinity purification; fermentation; chromatography; expanded bed adsorption. 1. Introduction One of the central challenges in delivering vaccines and gene therapy products is to find a vector that is able to safely introduce the product to the target cells (1). The use of viral vectors has been questioned due to safety and regulatory concerns over their toxicity and immunogenicity (2). This led to the study of plasmid deoxyribonucleic acid (plasmid DNA (pDNA)) as a non-viral gene therapy expression vector, which has the dual advantages of being free from specific safety concerns associated with viruses and generally simpler to develop (3). In medical therapy, pDNA may be used to treat monogenic From: Methods in Molecular Biology, vol. 421: Affinity Chromatography: Methods and Protocols, Second Edition Edited by: M. Zachariou © Humana Press, Totowa, NJ 275
- Page 494: 248 Galaev and Mattiasson in biotec
- Page 498: 250 Galaev and Mattiasson 2.4. Sepa
- Page 502: 252 Galaev and Mattiasson 3.4. Sepa
- Page 506: 254 Galaev and Mattiasson ensure el
- Page 510: 17 Monolithic Bioreactors for Macro
- Page 514: Monolithic Bioreactors for Macromol
- Page 518: Monolithic Bioreactors for Macromol
- Page 522: Monolithic Bioreactors for Macromol
- Page 526: Monolithic Bioreactors for Macromol
- Page 530: Monolithic Bioreactors for Macromol
- Page 534: Monolithic Bioreactors for Macromol
- Page 538: Monolithic Bioreactors for Macromol
- Page 542: Monolithic Bioreactors for Macromol
- Page 548: 276 Forde diseases, cancer and infe
- Page 552: 278 Forde 12. Sample loading buffer
- Page 556: 280 Forde 2. Mix 100 μl of sample,
- Page 560: 282 Forde 12. Safety Warning: Picog
- Page 564: 19 Affinity Chromatography of Phosp
- Page 568: Affinity Chromatography of Phosphor
- Page 572: Affinity Chromatography of Phosphor
- Page 576: Affinity Chromatography of Phosphor
- Page 580: Affinity Chromatography of Phosphor
- Page 584: 20 Protein Separation Using Immobil
- Page 588: Immobilized Phospholipid Chromatogr
- Page 592: Immobilized Phospholipid Chromatogr
18<br />
Plasmid DNA Purification Via the Use of a Dual<br />
Affinity Protein<br />
Gareth M. Forde<br />
Summary<br />
Methods are presented for the production, affinity purification and analysis of plasmid<br />
DNA (pDNA). Batch fermentation is used for the production of the pDNA, and expanded<br />
bed chromatography, via the use of a dual affinity glutathione S-transferase (GST) fusion<br />
protein, is used for the capture and purification of the pDNA. The protein is composed<br />
of GST, which displays affinity for glutathione immobilized to a solid-phase adsorbent,<br />
fused to a zinc finger transcription factor, which displays affinity for a target 9-base pair<br />
sequence contained within the target pDNA. A Picogreen fluorescence assay and/or an<br />
ethidium bromide agarose gel electrophoresis assay can be used to analyze the eluted pDNA.<br />
Key Words: Plasmid DNA; affinity purification; fermentation; chromatography;<br />
expanded bed adsorption.<br />
1. Introduction<br />
One of the central challenges in delivering vaccines and gene therapy<br />
products is to find a vector that is able to safely introduce the product to the<br />
target cells (1). The use of viral vectors has been questioned due to safety and<br />
regulatory concerns over their toxicity and immunogenicity (2). This led to the<br />
study of plasmid deoxyribonucleic acid (plasmid DNA (pDNA)) as a non-viral<br />
gene therapy expression vector, which has the dual advantages of being free<br />
from specific safety concerns associated with viruses and generally simpler<br />
to develop (3). In medical therapy, pDNA may be used to treat monogenic<br />
From: Methods in Molecular Biology, vol. 421: Affinity Chromatography: Methods and Protocols, Second Edition<br />
Edited by: M. Zachariou © Humana Press, Totowa, NJ<br />
275